Drug shortages: These factors lead to supply bottlenecks in the pharmaceutical industry

Competition between generics manufacturers makes supply chains more vulnerable

31-Mar-2023 - In a recent study, Prof. Dr. Kai Hoberg (KLU), Prof. Dr. David Francas (University of Applied Sciences Worms) and Stephan Mohr (Frankfurt School of Finance and Management) looked into which conditions affect the availability of drugs in Germany. One key finding: while competition between generics ...

This one-atom chemical reaction could transform drug discovery

This nearly unprecedented work could simplify and lower the cost of pharmaceutical synthesis

09-Feb-2023 - Pharmaceutical synthesis is often quite complex; simplifications are needed to speed up the initial phase of drug development and lower the cost of generic production. Now, in a study recently published in Science, researchers from Osaka University have discovered a chemical reaction that could ...

Price competition for generic drugs linked to increase in manufacturing-related recalls

01-Jun-2018 - Researchers from three universities have found that extreme price competition in the generic pharmaceutical market -- designed to make medications more affordable -- may be putting more patients at serious health risk, as evidenced by a higher number of product recalls caused by ...

Sanofi sells European generics business

18-Apr-2018 - Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi's European generics business for €1,9 billion. Advent's offer is firm, binding and fully financed. Advent is a global investor, with over 25 years' experience of investing in ...

As competition goes down, generic drug prices rise

06-Jul-2017 - If the cost of your generic prescription drug has risen, it may be due to a lack of competition among drug manufacturers, according to a University of Florida College of Pharmacy study. More than four in five prescriptions filled in the U.S. are for generic drugs, and UF researchers have found ...

Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals

11-Jul-2016 - Nichi-Iko Pharmaceutical Co. and Sagent Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement under which Nichi-Iko will acquire Sagent via an all-cash tender offer (the “Tender Offer”) followed by a second-step merger, for a total consideration of ...

Sun Pharma announces closure of merger deal with Ranbaxy

26-Mar-2015 - Sun Pharmaceutical Industries Ltd. begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth. The merger has fortified Sun Pharma’s position as the world’s fifth ...

UF Health researchers investigate effectiveness of a generic heart drug

09-Mar-2015 - University of Florida Health researchers are investigating whether a generic form of a common heart medicine used for high blood pressure, heart failure and many other conditions works as well as the brand-name prescription. Through a $2.3 million, three-year grant from the U.S. Food and Drug ...

UCB to sell its U.S. specialty generics business Kremers Urban for US$ 1,525 million

10-Nov-2014 - UCB, Advent International and Avista Capital Partners, two private equity firms with a strong healthcare focus, announced they have entered into a definitive agreement providing for the acquisition of UCB’s US specialty generics subsidiary, Kremers Urban Pharmaceuticals Inc. ("KU"), by Advent and ...

Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan

Abbott will retain its branded generics pharmaceuticals business in emerging markets

16-Jul-2014 - Abbott announced that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business, and will be a publicly traded company. ...